Correlation Between PDS Biotechnology and Poseida Therapeutics
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Poseida Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Poseida Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Poseida Therapeutics, you can compare the effects of market volatilities on PDS Biotechnology and Poseida Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Poseida Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Poseida Therapeutics.
Diversification Opportunities for PDS Biotechnology and Poseida Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between PDS and Poseida is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Poseida Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Poseida Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Poseida Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Poseida Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Poseida Therapeutics go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Poseida Therapeutics
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Poseida Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 2.74 times less risky than Poseida Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Poseida Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 218.00 in Poseida Therapeutics on September 2, 2024 and sell it today you would earn a total of 713.00 from holding Poseida Therapeutics or generate 327.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Poseida Therapeutics
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Poseida Therapeutics |
PDS Biotechnology and Poseida Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Poseida Therapeutics
The main advantage of trading using opposite PDS Biotechnology and Poseida Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Poseida Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Poseida Therapeutics will offset losses from the drop in Poseida Therapeutics' long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| Poseida Therapeutics vs. Molecular Partners AG | Poseida Therapeutics vs. Mineralys Therapeutics, Common | Poseida Therapeutics vs. AN2 Therapeutics | Poseida Therapeutics vs. Pharvaris BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |